QT
AMED

Quantamental Technologies’s Amedisys AMED Stock Holding History

Quantamental Technologies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-912
Closed -$223K – 287
2021
Q2 		$223K Buy
+912
New +$239K 0.2% 205
2020
Q3 		– Sell
-1,300
Closed -$258K – 256
2020
Q2 		$258K Buy
+1,300
New +$242K 0.17% 197
2019
Q2 		– Sell
-3,143
Closed -$387K – 1443
2019
Q1 		$387K Buy
+3,143
New +$394K 0.18% 159

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quantamental Technologies's AMED Position: Q3 2021 in Review

Quantamental Technologies sold out of Amedisys (AMED) in Q3 2021, closing a stake of 912 shares — an estimated $223K sold.

Quantamental Technologies first reported a position in AMED in Q1 2019 and held it in 3 quarters. The position peaked at $387K in Q1 2019. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Quantamental Technologies reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Quantamental Technologies sold 912 Amedisys shares in Q3 2021, an estimated $223K.
  • Quantamental Technologies first reported a position in Amedisys in Q1 2019 and held it in 3 quarters.
  • Quantamental Technologies's Amedisys position peaked at $387K in Q1 2019.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Quantamental Technologies's 13F filing for Q3 2021, filed 15 Nov 2021.